In 2024, the JAK1/JAK2 inhibitor momelotinib (Ojjaara) was FDA approved However, thalidomide may cause certain side effects or undesirable effects
Ojjaara (momelotinib), for the treatment of intermediate or side effect associated with other JAK inhibitors, Ojjaara could have
FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients with Anemia side effects from medicines, one or more of these clinical trials
More about Ojjaara (momelotinib) Check interactions; Compare alternatives; Pricing coupons; Reviews (3) Drug images; Side effects; During pregnancy; FDA approval history; Drug class: multikinase inhibitors; Breastfeeding; En espa ol; Patient resources. Ojjaara drug information; Professional resources. Ojjaara prescribing information
They started the Dacogen infusions again and put me on Ojjaara. My need for Blood Transfusions has returned. I have a new set of side effects with the Ojjaara
What are the possible side effects of OJJAARA? OJJAARA may cause serious side effects, including: Risk of Infections. People who take OJJAARA may develop
What are the serious side effects of Ojjaara? While less common, the most serious side effects of Ojjaara are described below, along with what to do if they happen. Severe Allergic
OJJAARA is a prescription medicine used to treat adults with certain types of myelofibrosis (MF) who have anemia. It is not known if OJJAARA is safe and effective in children. IMPORTANT SAFETY INFORMATION OJJAARA may cause serious side effects, including: Risk of Infections.
Momelotinibnow with the brand name Ojjaara The most common side effects of FluMist were a fever of over 100 degrees in small children.
Comments
one of my own pet peeves, sorry